Elucidate complex structures from experimental data with the help of expert algorithms
Synthetic biotechnology and ML to accelerate drug development, allowing researchers to discover, optimize, and characterize drugs more efficiently.
Lexlink AI is a practical tool crafted for paralegals and legal teams, which focuses on pinpointing inconsistencies and contradictions in case-related documents provided by opposing parties. It acts as a diligent assistant that sifts through extensive legal paperwork to highlight any discrepancies that could impact a case. Additionally, it can distill complex files into clear, concise summaries, helping legal professionals grasp the essentials without getting bogged down in details. Furthermore,
Pioneering an approach that combines simulation with machine learning, we map and model how thousands of signaling proteins interact characterizing cellular level cancer behavior and response or resistance to treatment. Our platform enables the simulation of drug-like effects from compounds that may not exist yet, on cells potentially unavailable for lab-based testing, like those of high unmet need cancer patients.
A biotechnology company to accelerate clinical trial design, regulatory affairs, and data management, and streamlines the development process through automation, allowing clients to make informed decisions, reduce costs, and ultimately improve patient outcomes
Fileread is a GenAI Application integrated into Relativity that helps litigators reach the heart of the matter faster without risking hallucination. It allows the litigation teams to collaborate securely and find critical information often missed through the traditional review. Fileread eliminates time-consuming document review, turning mountains of data into structured, actionable insights. With Fileread, litigation teams deliver the speed and accuracy clients demand while ensuring no crucial d
Powered by industry-leading ChemDraw® and Spotfire™, the Signals Research Suite delivers best-in-class analysis and data visualization for the Make-Test-Decide R&D life cycle, fostering rapid innovation in Pharma & Biotech and Chemicals & Materials. In Pharma & Biotech, the Suite is ideally suited for research use cases involving early and late-stage in vitro assays, cell line optimization, biologics process optimization, in vitro DMPK assays, animal pharmacokinetics studies, ef
ScienceMachine develops a biotechnology research system to accelerate biomedical discovery, enabling scientists in biotech and pharma to create a tailored data analysis pipeline to get to the answer by leveraging neuro-symbolic AI.
Nygen empowers leading experimental biologists to generate deep, actionable insights from their single-cell omics data. Our product suite is designed to help researchers unlock the full potential of single-cell data, driving innovation in clinical trials, diagnostics, and therapeutic decision-making with robust, scalable solutions. Nygen Analytics Our flagship platform for single-cell multi-omics analysis combines no-code pipelines, reproducibility, traceability, and a highly scalable infrastr
Quick-turn, lower-cost eDiscovery / early case assessment
Lifecycle e-discovery report
Data ingestion, processing, streaming analytics
Case management, workflow, and administration
Character Biosciences is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.
Tahoe Therapeutics is a biotechnology company that develops AI models of human cells to enhance drug discovery.
Aspect Analytics offers consultancy services, home-grown software, development of workflows, and customization of software.